JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $200,350 | +516.2% | 108,297 | +269.7% | 0.00% | – |
| Q4 2022 | $32,514 | -66.5% | 29,292 | -29.2% | 0.00% | – |
| Q3 2022 | $97,000 | -52.9% | 41,367 | -39.2% | 0.00% | – |
| Q2 2022 | $206,000 | -61.8% | 68,055 | -14.3% | 0.00% | – |
| Q1 2022 | $539,000 | -18.8% | 79,400 | -0.3% | 0.00% | – |
| Q4 2021 | $664,000 | +42.8% | 79,600 | +27.2% | 0.00% | – |
| Q3 2021 | $465,000 | -52.0% | 62,600 | -56.1% | 0.00% | – |
| Q2 2021 | $969,000 | -14.3% | 142,508 | +29.4% | 0.00% | – |
| Q1 2021 | $1,131,000 | -26.6% | 110,122 | -50.0% | 0.00% | – |
| Q4 2020 | $1,540,000 | -10.9% | 220,056 | +3.9% | 0.00% | – |
| Q3 2020 | $1,729,000 | +805.2% | 211,817 | +664.7% | 0.00% | – |
| Q2 2020 | $191,000 | -38.2% | 27,700 | -57.5% | 0.00% | – |
| Q1 2020 | $309,000 | -63.9% | 65,100 | -33.7% | 0.00% | – |
| Q4 2019 | $857,000 | +732.0% | 98,125 | +216.1% | 0.00% | – |
| Q3 2019 | $103,000 | -86.0% | 31,041 | -79.1% | 0.00% | – |
| Q2 2019 | $735,000 | +165.3% | 148,558 | +232.9% | 0.00% | – |
| Q1 2019 | $277,000 | +218.4% | 44,623 | +73.6% | 0.00% | – |
| Q4 2018 | $87,000 | -94.4% | 25,708 | -89.3% | 0.00% | – |
| Q3 2018 | $1,562,000 | +8.2% | 240,282 | +27.4% | 0.00% | – |
| Q2 2018 | $1,444,000 | -82.3% | 188,612 | -48.4% | 0.00% | -100.0% |
| Q1 2018 | $8,170,000 | +2346.1% | 365,550 | +1294.2% | 0.00% | – |
| Q4 2017 | $334,000 | – | 26,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |